APP, Human (Crenezumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.

Search, find, compare suppliers for anti-APP, Human (Crenezumab biosimilar) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityAPP, Human (Crenezumab biosimilar)
CloneCrenezumab
Host SpeciesRecombinant
Reactive Specieshuman
IsotypeIgG4 kappa
Formatpurified
Size1mg, 5mg
Concentration1mg/ml
Applicationsn/a
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionAnti-Human APP Recombinant Antibody (Crenezumab). Crenezumab is a fully humanized monoclonal antibody against human 1-40 and 1-42 Beta amyloid, which is being investigated as a treatment of Alzheimer's disease. Crenezumab is highly homologous to solanezumab, another monoclonal antibody targeting amyloid- peptides.
Immunogenn/a
Other NamesAnti-APP Recombinant Antibody, Research Grade Crenezumab, Anti-Human APP Recombinant Antibody(Crenezumab), MABT5102A, RG7412, Antibody Drug Analogues, Monoclonal Antibody, YR1256, Research Grade Biosimilars, Biosimilar Antibody
Gene, Accession #CAS: 1095207-05-8
Catalog #YR1256
Priceplease inquire
Order / More InfoAPP, Human (Crenezumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.
Product Specific Referencesn/a
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
FL-4, Building A5
International Enterprise Community
Tianjin CHINA
P: 400-621-6806

info@kmdbioscience.com
Sales: sales@kmdbiosci.com

https://www.kmdbioscience.com

Profile of KMD BIOSCIENCE CO. LTD.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.